If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTreatt Regulatory News (TET)

  • This share is currently suspended. It was suspended at a price of 305.00
  • There is currently no data for TET

Trading Statement

30 Sep 2013 07:00

RNS Number : 1767P
Treatt PLC
30 September 2013
 

 

 

30 September 2013

 

TREATT PLC

Pre-Close Trading Update for year ending 30 September 2013

Treatt PLC (the 'Group'), the manufacturer and supplier of conventional, organic and fair traded ingredient solutions for the flavour, fragrance and consumer goods industries today publishes a pre-close period trading update for the year ending 30 September 2013.

Following the Q3 IMS published on 1 August 2013, the Board is pleased to confirm that trading in Q4 has remained steady across the Group, following a strong Q3. Although the final quarter of the financial year is seasonally a quieter period for the Group, this year Q4 has held up well. As a consequence, the Group expects to report profits before tax and exceptional items in line with its expectations. The exceptional items relate to legal and professional fees in respect of litigation arising from the acquisition of the Earthoil Group in 2008, and the company's costs in respect of the shareholder matters that arose earlier in the year. Whilst profit before tax is expected to meet the Board's expectations which were revised upwards in May, revenue from our lower margin business is expected to be a little lower than anticipated due to customer product mix variations and market conditions for some ingredients. This affected revenues but had little impact on profits.

Looking beyond the current financial year, order books for the first quarter of the new financial year, which is seasonally the Group's weakest quarter, are encouraging. The coming year will be the first full financial year to see the benefits of the new strategy with its focus on selling added-value ingredient solutions to leading FMCG and beverage businesses, whilst maintaining a tight control of costs.

Treatt Plc's results for the year ending 30 September 2013 will be announced on 9 December 2013.

 

For further information please contact:

 

Daemmon Reeve

Chief Executive Officer

 

Richard Hope

Finance Director

01284 702500

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTDMGZLVNFGFZM
Date   Source Headline
13th May 202610:19 amRNS20260512_TREATT PLC_8.5 EPT RI_UK_MLI
13th May 20269:34 amRNSForm 8.3 Treatt Plc
12th May 20263:07 pmRNSForm 8.3 - TREATT PLC
12th May 20262:44 pmRNSForm 8.3 TREATT PLC
12th May 202612:00 pmRNSForm 8.5 (EPT/RI) Treatt PLC
12th May 202610:27 amRNSForm 8.3 Treatt plc
12th May 20267:00 amRNSPublication and Posting of Scheme Document
11th May 20265:38 pmRNSOpening Position Disclosure - Replacement
11th May 202612:06 pmRNSForm 8.3 TREATT PLC
11th May 202612:00 pmRNSForm 8.5 (EPT/RI) Treatt plc
11th May 202610:47 amRNS20260508_TREATT PLC_8.5 EPT RI_UK_MLI
11th May 202610:18 amRNSForm 8.3 Treatt Plc
8th May 20263:54 pmRNSHolding(s) in Company
8th May 20263:20 pmRNSForm 8.3 TREATT PLC
8th May 20263:20 pmRNSForm 8.3 - Treatt plc
8th May 202612:12 pmRNSForm 8.3 Treatt plc
8th May 202612:00 pmRNSForm 8.5 (EPT/RI) Treatt plc
8th May 202610:49 amRNS20260507_TREATT PLC_8.5 EPT RI_UK_MLI
8th May 20269:21 amGNWForm 8.5 (EPT/RI)-Treatt Plc
8th May 20269:21 amBUSForm 8.5 (EPT/RI)-Treatt Plc
8th May 20269:08 amRNSUpdate on Letters of Intent
7th May 20263:44 pmRNSForm 8.3 - Treatt PLC
7th May 20263:42 pmRNSForm 8.3 - Treatt PLC
7th May 20263:39 pmRNSForm 8.3 - Treatt PLC
7th May 20263:34 pmRNSForm 8.3 - Treatt PLC
7th May 20263:28 pmRNSForm 8.3 TREATT PLC
7th May 20263:25 pmRNSForm 8.3 - Treatt plc
7th May 20263:04 pmRNSForm 8.3 - Treatt PLC
7th May 20261:17 pmRNSForm 8.3 - Treatt plc
7th May 202612:20 pmRNSForm 8.3 Treatt plc
7th May 202612:00 pmRNSForm 8.5 (EPT/RI) Treatt plc
7th May 202611:44 amRNSOpening Position Disclosure
7th May 202610:37 amRNS20260506_TREATT PLC_8.5 EPT RI_UK_MLI
7th May 20267:00 amRNSUpdate on Letters of Intent
7th May 20267:00 amRNSForm 8.3 - Treatt plc - Replacement
6th May 20263:12 pmRNSForm 8.3 - TREATT PLC
6th May 20261:21 pmRNSForm 8.3 TREATT PLC
6th May 20261:17 pmRNSForm 8.3 - Treatt Plc
6th May 202612:18 pmRNSForm 8.3 Treatt plc
6th May 202612:00 pmRNSForm 8.5 (EPT/RI) Treatt plc
6th May 202611:34 amRNS20260505_TREATT PLC_8.5 EPT RI_UK_MLI
6th May 20267:00 amRNSUpdate on Letters of Intent
5th May 20263:17 pmRNSForm 8.3 - TREATT PLC
5th May 202612:22 pmRNSForm 8.3 Treatt Plc
5th May 202612:14 pmRNSForm 8.3 - Treatt PLC
5th May 202612:00 pmRNSForm 8.5 (EPT/RI) Treatt plc
5th May 20268:09 amRNSForm 8.3 TREATT PLC
5th May 20267:00 amRNSForm 8.5 (EPT/RI) - Treatt plc
1st May 20264:30 pmRNSUpdate on Letters of Intent
1st May 20263:50 pmRNSForm 8 (Opening Position Disclosure)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.